PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

At this point Gan Gans I agree that you are correct to question...

  1. 1,039 Posts.
    lightbulb Created with Sketch. 94
    At this point Gan Gans I agree that you are correct to question “why would a post surgical patient be on iPPS”. ?
    Not sure on what basis or medical terms PAR could access that part of the market however inflammation appears to be one of the great addressable features of Zilusol. After chatting with PR last Thursday he is actually going to assist me to access some for my post surgical hip replacement on the basis that various body compensations are taking place as it adjusts to that big hunk of inserted metal. Ala inflammation, tight muscles in hamstrings, lower back and shoulders.
    Post surgery could be a massive assist for patient recovery but will let you know how it goes as things progress.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.